Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Molecular therapy for gastric cancer
1Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. yayamada@ncc.go.jp.
Targeted therapies, like anti-HER2 antibody, show promise for HER2-positive gastric cancer. Further translational research is needed to identify new targets and drugs for personalized gastric cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Translational Research
Background:
- Gastric cancer treatment has explored molecularly targeted agents.
- Anti-HER2 antibody combined with chemotherapy improves survival in HER2-positive gastric cancer.
- This represents a successful targeted therapy for gastric cancer.
Purpose of the Study:
- To review the success of targeted agents in gastric cancer.
- To highlight the need for identifying new molecular targets.
- To emphasize the development of personalized medicine approaches and novel drug candidates for gastric cancer.
Main Methods:
- Review of preclinical and clinical studies on targeted agents for gastric cancer.
- Analysis of the efficacy of anti-HER2 antibody in HER2-positive gastric cancer.
- Discussion on translational research strategies for drug discovery.
Main Results:
- Anti-HER2 antibody offers significant survival benefits in HER2-positive gastric cancer patients.
- Targeted therapy is the only successful approach currently shown for gastric cancer treatment.
- The success of anti-HER2 antibody validates targeted therapy strategies.
Conclusions:
- Translational research is crucial for discovering specific molecular targets in gastric cancer.
- Development of precise diagnostics is essential for personalized gastric cancer medicine.
- Identifying novel drug candidates is a key future direction for gastric cancer therapy.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Treatment Resistant Cancers